Screener
Edgewise Therapeutics, Inc. EWTX Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Edgewise Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 8:09 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056713
| Assets | As of / March 31, 2026 / (unaudited) | As of / December 31, 2025 |
|---|---|---|
| Stockholders' equity: | ||
| Preferred stock, $.0001 par value per share; 200,000,000 shares authorized and no shares issued or outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $.0001 par value per share; 1,000,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 107,481,522 shares and 106,249,579 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 10 | 10 |
| Additional paid-in capital | 1,088,829 | 1,067,941 |
| Accumulated other comprehensive income (loss) | (252) | 677 |
| Accumulated deficit | (595,384) | (546,371) |
| Total stockholders' equity | 493,203 | 522,257 |
| Total liabilities and stockholders' equity | $518,522 | $552,603 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Edgewise Therapeutics, Inc.'s retained earnings?
- Edgewise Therapeutics, Inc. (EWTX) reported retained earnings of -$595.38M in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s retained earnings changed year-over-year?
- Edgewise Therapeutics, Inc.'s retained earnings decreased by 42.0% year-over-year, from -$419.37M to -$595.38M.
- What is the long-term trend for Edgewise Therapeutics, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Edgewise Therapeutics, Inc.'s retained earnings has grown at a 74.1% compound annual growth rate (CAGR), from -$34.15M to -$546.37M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Edgewise Therapeutics, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude